Metastatic non-muscle invasive bladder cancer with cervical lymph node metastasis

AUTOR(ES)

Garrido-Abad, Pablo

FONTE

Int. braz j urol.

DATA DE PUBLICAÇÃO

20/12/2019

RESUMO

ABSTRACT Bladder cancer is a common cancer that may present as superficial, invasive, or metastatic disease. Non-muscle-invasive bladder cancer (NMIBC) represents the majority of bladder cancer diagnoses, but represents a spectrum of disease with a variable clinical course, notably for significant risk of recurrence and potential for progression. NMIBC metastasis to distant organs without local invasion or regional metastasis is a very rare occurrence, so there are limited case reports about early metastasis in the literature.

Documentos Relacionados

• Are we following the guidelines on non-muscle invasive bladder cancer?
• The prognostic impact of tumor necrosis in non-muscle invasive bladder cancer
• Neutrophil to lymphocyte ratio, a biomarker in non-muscle invasive bladder cancer: a single-institutional longitudinal study
• Clinical significance of serum and urinary HER2/neu protein levels in primary non-muscle invasive bladder cancer
• Urovysion™ testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer